Jasper Therapeutics, Inc. — Form 8-K Summary
Business context and reporting period
On September 22, 2021, Amplitude Healthcare Acquisition Corporation (“AMHC”), a special purpose acquisition company, held a special meeting of stockholders regarding its proposed business combination with Jasper Therapeutics, Inc. Upon closing, AMHC was expected to be renamed Jasper Therapeutics, Inc., and Jasper was expected to be renamed Jasper Tx Corp. The filing reports stockholder voting results and transaction-related developments; it does not provide operating results for Jasper.
Key financial and transaction metrics
- Jasper’s agreed transaction equity value was $275.0 million.
- Stockholders representing 9,872,643 shares, or 78.9% of AMHC’s outstanding common stock as of the August 20, 2021 record date, were present in person or by proxy.
- The transaction contemplated issuing up to 27.5 million shares of New Jasper common stock, including shares issued in the business combination and the PIPE investment.
- The minimum cash condition was $130.0 million, based on trust-account proceeds after redemptions plus PIPE proceeds.
- There were 9,262,099 Class A common stock redemptions in connection with the business combination. Jasper agreed to waive the minimum cash condition as a result.
- The filing does not provide a clear final amount of cash available after redemptions, PIPE proceeds, or post-transaction liquidity.
- The filing does not provide revenue, profit or loss, cash flow, margins, debt, or other operating financial metrics.
Material changes and transaction developments
- All proposals presented at the special meeting were approved, including the business combination, charter and bylaws amendments, Nasdaq-related share issuance, director appointments, equity incentive plan, employee stock purchase plan, and adjournment proposal.
- The business combination proposal passed with 9,366,228 votes for, 506,415 against, and no abstentions.
- Five directors were approved: Kurt von Emster, Anna French, D.Phil., Judith Shizuru, M.D., Ph.D., William Lis, and Christian W. Nolet.
- The proposed charter would authorize 490.0 million voting common shares, 2.0 million non-voting common shares, and 10.0 million preferred shares.
- The Sponsor agreed to forfeit 200,000 shares of AMHC Class B common stock and receive 2.3 million shares of New Jasper voting common stock at closing. Of those shares, 1.05 million would be subject to earnout conditions.
- Earnout releases were tied to 30-day volume-weighted average prices of $11.50, $15.00, and $18.00 during the period through the third anniversary of closing, for 250,000, 500,000, and 300,000 shares, respectively.
Guidance, outlook, risks, contingencies, and unusual items
- The filing does not provide financial guidance or an operating outlook.
- Closing remained subject to the other conditions in the business combination agreement, although Jasper waived the $130.0 million minimum cash condition following the redemptions.
- The high level of redemptions reduced available transaction cash and represents a material financing and liquidity consideration.
- The transaction involved substantial potential share issuance, sponsor earnout arrangements, and amendments to corporate governance documents, which may affect dilution, control, and shareholder rights.
- The filing states that the press release announcing approval of the business combination was filed as Exhibit 99.1.
Important facts for investors to verify
- Whether and when the business combination formally closed, including the effective date and final post-closing capitalization.
- The final cash balance, trust-account proceeds, PIPE financing proceeds, and use of transaction funds after the 9,262,099 redemptions.
- The number of shares issued to Jasper securityholders and PIPE investors and the resulting dilution to public stockholders.
- Jasper’s subsequent financial statements, including revenue, operating expenses, cash burn, debt, and liquidity runway.
- The final status and potential impact of the Sponsor earnout shares and related stock-price triggers.